(Q35640645)

9 August 2017

title

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine (English)

1 reference

9 August 2017

1 reference

0 references

14

M Juliana McElrath

1 reference

9 August 2017

Yunda Huang

11

0 references

Susan Buchbinder

10

object named as

Susan P Buchbinder

1 reference

9 August 2017

8

Ann Duerr

1 reference

9 August 2017

7

Danilo R Casimiro

1 reference

9 August 2017

5

Olivier D Defawe

1 reference

9 August 2017

13

Stephen C De Rosa

1 reference

9 August 2017

1

Nicole Frahm

1 reference

9 August 2017

2

Allan C DeCamp

1 reference

9 August 2017

6

James G Kublin

1 reference

9 August 2017

David P Friedrich

3

1 reference

9 August 2017

Donald K Carter

4

1 reference

9 August 2017

Michael N Robertson

9

1 reference

9 August 2017

Gregory A Spies

12

1 reference

9 August 2017

language of work or name

English

0 references

publication date

27 December 2011

1 reference

Journal of Clinical Investigation

9 August 2017

published in

1 reference

9 August 2017

volume

122

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

359-367

1 reference

Novel adenovirus vector-based vaccines for HIV-1.

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

The magnitude of CD4+ T cell recall responses is controlled by the duration of the secondary stimulus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Host immune responses to chronic adenovirus infections in human and nonhuman primates.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

T-cell response to adenovirus hexon and DNA-binding protein in mice

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Extensive cross-reactivity of adenovirus-specific cytotoxic T cells

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248307

Worldwide epidemiology of human adenovirus infections

15 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22201684

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Human T Cell Proliferative Response to Polypeptides from Adenovirus Type 2

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22201684

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1172/JCI60202

1 reference

9 August 2017

1 reference

9 August 2017

1 reference